Answers are grounded in this paper and cite their sources.
Alloimmunization is an immune response against red blood cell (RBC) antigens due to sensitization during RBC transfusion. RBC alloimmunization is more common in sickle cell disease (SCD) with prevalence between 18 and 47%.
No takes yet. Share an insight, caveat, or question.
Cardoso et al. (2020) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: